OS Therapies secures up to $15M equity line from Square Gate Capital over 24 months

OS Therapies Inc

Company can sell up to $15M of common stock to Square Gate at 95% of lowest VWAP during valuation period.
Investor prohibited from short sales or hedging; no warrants issued in the transaction.
Initial commitment shares equal to 3% of $15M issued as consideration to the investor.
Proceeds will fund clinical development programs and expand discovery and preclinical activities.
Registration statement covering resale of shares to be filed with SEC by November 15, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.